| Old Articles: <Older 27261-27270 Newer> |
|---|
 |
The Motley Fool
November 15, 2007
Rich Smith |
Rupert Murdoch Is Four Times Stupid It's official. The Wall Street Journal's online edition, WSJ.com, will be free to all comers; management expects readership to jump from 1 million to 15 million with the change.   |
The Motley Fool
November 15, 2007
Rich Smith |
Buyers Behaving Badly The developing crisis of confidence in high-powered private equity presents mere mortal investors with both danger and opportunity. |
The Motley Fool
November 15, 2007
David Lee Smith |
Automakers' Results in the Rear View Let's look back and compare the quarterly results of these three big auto manufacturers: Toyota... General Motors... Ford... |
The Motley Fool
November 15, 2007
Morgan Housel |
3 Myths About the Turbulent Market The stock market has been a wild ride lately; investors, be careful to not fall into these common investing traps. |
The Motley Fool
November 15, 2007
Rick Aristotle Munarriz |
Is MercadoLibre the Next eBay? The Latin American auctioneer MercadoLibre sparkles in its first public quarter. |
The Motley Fool
November 14, 2007
Timothy M. Otte |
Play the "Pot Odds" in Retail In past years there has always been the assumption that some retail companies, especially those best positioned going into the season, would do well, but how about this year? Is there enough upside to hold any retail stocks through these holidays? |
The Motley Fool
November 14, 2007
Jack Uldrich |
The Week in Innovation Investors interested in the future of robotic medical technology, such as neurosurgical robots, carbon nanotubes, and printable organs, should keep an eye on these companies: Intuitive Surgical... IMRIS... Hansen Medical... Stereotaxis... |
The Motley Fool
November 14, 2007
Morgan Housel |
Patience, Grasshopper Don't let the impatience of our fast-paced life persuade you to demand instant success from your investments. In the world of finance, one thing has stayed the same over the years; if you want to do well, you must have patience. |
The Motley Fool
November 14, 2007
Brian Lawler |
Busy Times Ahead for Cardiome Keep an eye on Canadian drug developer Cardiome Pharma over the next three months; its entire pipeline of drugs will be receiving regulatory scrutiny during this time. |
The Motley Fool
November 14, 2007
Alyce Lomax |
lululemon Chokes on Seaweed Recent IPO lululemon might suffer a blow to its integrity, after independent testing of its VitaSea apparel, which is supposed to consist of 24% seaweed fiber, is found to have no significant differences from run-of-the-mill cotton. |
| <Older 27261-27270 Newer> Return to current articles. |
